The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Open accessAbstract
Understanding molecular mechanisms that dictate B cell diversity is important for targeting B cells as anti-cancer treatment. Through the single-cell dissection of B cell heterogeneity in longitudinal samples of patients with breast cancer before and after neoadjuvant chemotherapy, we revealed that an ICOSL+ B cell subset emerges after chemotherapy. Using three immunocompetent mouse models, we recapitulated the subset switch of human tumor-infiltrating B cells during chemotherapy. By employing B-cell-specific deletion mice, we showed that ICOSL in B cells boosts anti-tumor immunity by enhancing the effector to regulatory T cell ratio. The signature of ICOSL+ B cells is imprinted by complement-CR2 signaling, which is triggered by immunogenic cell death. Moreover, we identified that CD55, a complement inhibitory protein, determines the opposite roles of B cells in chemotherapy. Collectively, we demonstrated a critical role of the B cell subset switch in chemotherapy response, which has implications in designing novel anti-cancer therapies. VIDEO ABSTRACT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
Varghese, F., Bukhari, A. B., Malhotra, R., & De, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096801 · Cited by 1,318
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
Wei, S. C., Levine, J. H., Cogdill, A. P., Zhao, Y., Anang, N.-A. A. S., Andrews, M. C., Sharma, P., Wang, J., Wargo, J. A., Pe’er, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.024 · Cited by 1,302
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
Self-citationModulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 772
Self-citationCD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Chen, F., Chen, J., Yang, L., Liu, J., Zhang, X., Zhang, Y., Tu, Q., Yin, D., Lin, D., Wong, P.-P., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0299-0 · Cited by 712
Self-citationComplement-dependent Clearance of Apoptotic Cells by Human Macrophages
Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2313 · Cited by 700
Olkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., Malchinkhuu, E., Wersto, R. P., & Biragyn, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4316 · Cited by 684
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
Galluzzi, L., Aaronson, S. A., Abrams, J., Alnemri, E. S., Andrews, D. W., Baehrecke, E. H., Bazan, N. G., Blagosklonny, M. V., Blomgren, K., Borner, C., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.44 · Cited by 680
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 590
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589
Decoding Cell Death Signals in Inflammation and Immunity
Zitvogel, L., Kepp, O., & Kroemer, G. (2010) · Cell · doi:10.1016/j.cell.2010.02.015 · Cited by 558
Novel mechanisms and functions of complement
Hajishengallis, G., Reis, E. S., Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2017) · Nature Immunology · doi:10.1038/ni.3858 · Cited by 488
Baumjohann, D., Preite, S., Reboldi, A., Ronchi, F., Ansel, K. M., Lanzavecchia, A., & Sallusto, F. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.020 · Cited by 484
CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development
Lehrman, E. K., Wilton, D. K., Litvina, E. Y., Welsh, C. A., Chang, S. T., Frouin, A., Walker, A. J., Heller, M. D., Umemori, H., Chen, C., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.017 · Cited by 468
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Huang, D., Chen, J., Yang, L., Ouyang, Q., Li, J., Lao, L., Zhao, J., Liu, J., Lu, Y., Xing, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0207-y · Cited by 448
Self-citationDieci, M. V., Radosevic-Robin, N., Fineberg, S., van den Eynden, G., Ternes, N., Penault-Llorca, F., Pruneri, G., D’Alfonso, T. M., Demaria, S., Castaneda, C., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.003 · Cited by 433
Follicular dendritic cells: dynamic antigen libraries
Heesters, B. A., Myers, R. C., & Carroll, M. C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3689 · Cited by 429
Complement in cancer: untangling an intricate relationship
Reis, E. S., Mastellos, D. C., Ricklin, D., Mantovani, A., & Lambris, J. D. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.97 · Cited by 425
Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
Schalper, K. A., Brown, J., Carvajal-Hausdorf, D., McLaughlin, J., Velcheti, V., Syrigos, K. N., Herbst, R. S., & Rimm, D. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju435 · Cited by 417
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Bonavita, E., Gentile, S., Rubino, M., Maina, V., Papait, R., Kunderfranco, P., Greco, C., Feruglio, F., Molgora, M., Laface, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.004 · Cited by 417
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
von Minckwitz, G., Blohmer, J. U., Costa, S. D., Denkert, C., Eidtmann, H., Eiermann, W., Gerber, B., Hanusch, C., Hilfrich, J., Huober, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.0940 · Cited by 414
Regulation of Humoral Immunity by Complement
Carroll, M. C., & Isenman, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.002 · Cited by 387
Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1408 · Cited by 352
Self-citationInhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E., Steinhoff, M., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 304
Self-citationImmune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
Su, S., Zhao, J., Xing, Y., Zhang, X., Liu, J., Ouyang, Q., Chen, J., Su, F., Liu, Q., & Song, E. (2018) · Cell · doi:10.1016/j.cell.2018.09.007 · Cited by 303
Self-citationEngagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
Fan, X., Quezada, S. A., Sepulveda, M. A., Sharma, P., & Allison, J. P. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130590 · Cited by 300
Characterization of Human Inducible Costimulator Ligand Expression and Function
Aicher, A., Hayden-Ledbetter, M., Brady, W. A., Pezzutto, A., Richter, G., Magaletti, D., Buckwalter, S., Ledbetter, J. A., & Clark, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4689 · Cited by 245
Hennequin, A., Derangère, V., Boidot, R., Apetoh, L., Vincent, J., Orry, D., Fraisse, J., Causeret, S., Martin, F., Arnould, L., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1054598 · Cited by 226
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Su, S., Liao, J., Liu, J., Huang, D., He, C., Chen, F., Yang, L., Wu, W., Chen, J., Lin, L., et al. (2017) · Cell Research · doi:10.1038/cr.2017.34 · Cited by 225
Self-citationFayanju, O. M., Ren, Y., Thomas, S. M., Greenup, R. A., Plichta, J. K., Rosenberger, L. H., Tamirisa, N., Force, J., Boughey, J. C., Hyslop, T., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002953 · Cited by 202
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice
Horikawa, M., Minard-Colin, V., Matsushita, T., & Tedder, T. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59266 · Cited by 191
Role of Complement in Induction of the Allergic Response
PEPYS, M. B. (1972) · Nature New Biology · doi:10.1038/newbio237157a0 · Cited by 179
Surace, L., Lysenko, V., Fontana, A. O., Cecconi, V., Janssen, H., Bicvic, A., Okoniewski, M., Pruschy, M., Dummer, R., Neefjes, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.009 · Cited by 179
Zhang, C., Xin, H., Zhang, W., Yazaki, P. J., Zhang, Z., Le, K., Li, W., Lee, H., Kwak, L. W., Forman, S. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.003 · Cited by 148
Innate immune mediators in cancer: between defense and resistance
Berraondo, P., Minute, L., Ajona, D., Corrales, L. P., Melero, I., & Pío, R. (2016) · Immunological Reviews · doi:10.1111/imr.12464 · Cited by 146
Bodogai, M., Lee-Chang, C., Wejksza, K., Lai, J., Merino, M. J., Wersto, R. P., Gress, R. E., Chan, A. C., Hesdorffer, C., & Biragyn, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4184 · Cited by 144
Wang, R. H., Phillips, G., Medof, M. E., & Mold, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116706 · Cited by 124
Zhu, W., Germain, C., Liu, Z., Sebastian, Y., Devi-Marulkar, P., Knockaert, S., Brohawn, P. Z., Lehmann, K. P., Damotte, D., Validire, P., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1051922 · Cited by 118
The clinical impact of ICOS signal in colorectal cancer patients
Zhang, Y., Luo, Y., Qin, S., Mu, Y., Yang, Q., Yu, M., & Zhong, M. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1141857 · Cited by 104
B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging
Keren, Z., Naor, S., Nussbaum, S., Golan, K., Itkin, T., Sasaki, Y., Schmidt-Supprian, M., Lapidot, T., & Melamed, D. (2011) · Blood · doi:10.1182/blood-2010-09-307983 · Cited by 100
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop
Wang, Y., Chen, J., Yang, L., Li, J., Wu, W., Huang, M., Lin, L., & Su, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2544 · Cited by 100
Self-citationTaylor, R. P., & Lindorfer, M. A. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.003 · Cited by 98
B cells and their mediators as targets for therapy in solid tumors
Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 82
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection
Metzger, T. C., Long, H., Potluri, S., Pertel, T., Bailey-Bucktrout, S. L., Lin, J. C.-Y., Fu, T., Sharma, P., Allison, J. P., & Feldman, R. M. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3412 · Cited by 71
Aklilu, M., Stadler, W. M., Markiewicz, M. A., Vogelzang, N. J., Mahowald, M. B., Johnson, M. B., & Gajewski, T. F. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh280 · Cited by 62
Mastellos, D. C. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.019 · Cited by 62
Untch, M., von Minckwitz, G., Gerber, B., Schem, C., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Hanusch, C. A., Huober, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.9175 · Cited by 61
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)
Khandelwal, S., Lee, G. M., Hester, C. G., Poncz, M., McKenzie, S. E., Sachais, B. S., Rauova, L., Kelsoe, G. H., Cines, D. B., Frank, M., et al. (2016) · Blood · doi:10.1182/blood-2016-04-709634 · Cited by 50
The versatile functions of complement C3‐derived ligands
Erdei, A., Sándor, N., Mácsik‐Valent, B., Lukácsi, S., Kremlitzka, M., & Bajtay, Z. (2016) · Immunological Reviews · doi:10.1111/imr.12498 · Cited by 43
Cutting Edge: Complement (C3d)-Linked Antigens Break B Cell Anergy
Lyubchenko, T. A., Porto, J. M. D., Holers, V. M., & Cambier, J. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2695 · Cited by 39
Franzese, O., Palermo, B., Donna, C. D., Sperduti, I., Ferraresi, V., Stabile, H., Gismondi, A., Santoni, A., & Nisticò, P. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1114203 · Cited by 39
Rituximab efficiently depletes B cells in lung tumors and normal lung tissue
Joly-Battaglini, A., Hammarström, C. L., Stankovic, B., Aamodt, H., Stjärne, J., Brustugun, O. T., Helland, Å., Øynebråten, I., & Corthay, A. (2016) · F1000Research · doi:10.12688/f1000research.7599.1 · Cited by 17
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 880
Fridman, W. H., Meylan, M., Petitprez, F., Sun, C.-M., Italiano, A., & Sautès-Fridman, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00619-z · Cited by 657
Vanhersecke, L., Brunet, M., Guégan, J.-P., Rey, C., Bougouin, A., Cousin, S., Le Moulec, S., Besse, B., Loriot, Y., Larroquette, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00232-6 · Cited by 632
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P., & Nelson, B. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00466-1 · Cited by 524
Metadata
- Authors
- Lu, Y., Zhao, Q., Liao, J.-Y., Song, E., Xia, Q., Pan, J., Li, Y., Li, J., Zhou, B., Ye, Y., Di, C., Yu, S., Zeng, Y., & Su, S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 180
- Issue
- 6
- Pages
- 1081-1097.e24
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3009921395
- Cited by
- 280
- References
- 65
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.